Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
IDEAYA Biosciences
OncoC4, Inc.
Memorial Sloan Kettering Cancer Center
Arcus Biosciences, Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
AstraZeneca
City of Hope Medical Center
University Health Network, Toronto
NeoTX Therapeutics Ltd.
BicycleTx Limited
Memorial Sloan Kettering Cancer Center
Sensei Biotherapeutics, Inc.
Cancer Research UK
Tempus AI
Carisma Therapeutics Inc
Invitae Corporation
Adaptimmune
ImmunoVaccine Technologies, Inc. (IMV Inc.)